IMMUNETHEP

Portugal
Cantanhede, Coimbra, Portugal, 3060-197

Company profile

IMMUNETHEP company profile

Immunethep is a biotechnology company focused on drug development for Immune System related pathologies. Immunethep is a spin-off from the University of Porto that uses its proprietary technology to address unmet medical needs. Immunethep discovered a novel mechanism used by different pathogenic bacteria to suppress host immune response. By targeting this mechanism we are developing broad coverage anti-bacterial immunotherapies.

Business identity

Contact email
[email protected]
Phone number
+351231419042
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2013-10-16

Headquarters

Postal code
3060-197
Country code
PT
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
7
Last funding
Grant / $1.3M / 2025-03-01
Last equity funding
Series Unknown
Investors
5
Lead investors
4
Founders
6
Articles
1

Founders and investors

Founders

Agostinho João AlmeidaBruno SantosHugo RamosJoão FerreiraPedro MadureiraRafael Simão

Lead investors

Bill & Melinda Gates FoundationEuropean Innovation CouncilPACE-AMRPortugal Ventures

Investors

Bill & Melinda Gates FoundationEuropean Innovation CouncilPACE-AMRPortugal VenturesVenture Catalysts